Blog

4 of the Most Groundbreaking Startups

July 7, 2017

Philadelphia is the City of Brotherly Love. It is gaining the reputation of a fast growing entrepreneurial ecosystem. As a diverse city, it is home to innovative science and information technology (IT) startups. Progressive Policy Institute, a non-profit organization, and Telnet, an IT solutions consulting firm, are responsible for creating a report on startups around […]

Phenom People Named an IDC Innovator in New Talent Discovery Report

July 6, 2017

Phenom People, the leader in Talent Relationship Marketing, today shared details of the company’s inclusion in a new report from International Data Corporation (IDC) titled “IDC Innovators: Talent Discovery, 2017.” Focused on emerging trends in talent acquisition and staffing, the report recognized Phenom People as an IDC Innovator for its Talent Relationship Marketing (TRM) platform. […]

Five Reasons to Attend the PHL Innovation Picnic

June 19, 2017

By now you have probably heard about the PHL Innovation Picnic, and for good reason (see below), but you might not have purchased your tickets yet. No worries, we are here to give you five more reasons to click accept on our ticketleap page. Don’t get us wrong, there are many more than five reasons […]

Announcing the 2017 SustainPHL Nominees

June 6, 2017

We’re excited to announce the 2017 nominees for SustainPHL! First and foremost, we can’t believe how awesome the nominations submissions were. Thank you for sharing over 150 organizations and individuals with us. How we determined the below list: We listened to our 2016 attendees and worked with B Lab to create a list of criteria for […]

Cagent Vascular Completes Enrollment of PRELUDE Study Using Serranator Device

June 5, 2017

Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular disease interventions, including the FDA 510(k) cleared Serranator® Alto PTA Serration Balloon Catheter, announces the completion of enrollment in the First-in-Human PRELUDE Study. The purpose of this prospective, single-arm, multicenter feasibility study is to show the safety and efficacy of the Serranator® […]